title: The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms.
abstract: OBJECTIVE
  To determine the incremental cost-effectiveness of magnetic resonance imaging (MRI) and computed tomography (CT) in young adults presenting with equivocal neurological signs and symptoms.
  
  
  METHODS
  A decision analysis of long-term survival using accuracy data from a diagnostic technology assessment of MRI and CT in patients with suspected multiple sclerosis, information from the medical literature, and clinical assumptions.
  
  
  RESULTS
  In the baseline analysis, at 30% likelihood of an underlying neurologic disease, MRI use has an incremental cost of $101,670 for each additional quality-adjusted life-year saved compared with $20,290 for CT use. As the probability of disease increases, further MRI use becomes a cost-effective alternative costing $30,000 for each quality-adjusted life-year saved. If a negative MRI result provides reassurance, the incremental costs of immediate MRI use decreases and falls below $25,000 for each quality-adjusted life-year saved no matter the likelihood of disease.
  
  
  CONCLUSIONS
  For most individuals with neurological symptoms or signs, CT imaging is cost-effective while MR imaging is not. The cost-effectiveness of MRI use, however, improves as the likelihood of an underlying neurological disease increases. For selected patients who highly value diagnostic information, MRI is a reasonable and cost-effective use of medical resources when even the likelihood of disease is quite low (5%).
authors.affiliation: University of Rochester, USA.
authors.forename: A I
authors.initials: AI
authors.lastname: Mushlin
authors.forename: C
authors.initials: C
authors.lastname: Mooney
authors.forename: R G
authors.initials: RG
authors.lastname: Holloway
authors.forename: A S
authors.initials: AS
authors.lastname: Detsky
authors.forename: D H
authors.initials: DH
authors.lastname: Mattson
authors.forename: C E
authors.initials: CE
authors.lastname: Phelps
mesh_terms: D000328:Adult; D002493:Central Nervous System Diseases / Q000175:diagnosis* / Q000191:economics; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000191:economics*; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000191:economics; D019057:Quality-Adjusted Life Years; D014057:Tomography, X-Ray Computed / Q000191:economics